HEADER HYDROLASE 07-DEC-20 7B63 TITLE STRUCTURE OF NUDT15 IN COMPLEX WITH TH7755 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROBABLE 8-OXO-DGTP DIPHOSPHATASE NUDT15; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 8-OXO-DGTPASE NUDT15,7,8-DIHYDRO-8-OXOGUANINE-TRIPHOSPHATASE COMPND 5 NUDT15,MUTT HOMOLOG 2,MTH2,NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X COMPND 6 MOTIF 15,NUDIX MOTIF 15; COMPND 7 EC: 3.6.1.9; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NUDT15, MTH2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS INHIBITOR, COMPLEX, NUCLEOSIDE TRIPHOSPHATE PYROPHOSPHOHYDROLASE, KEYWDS 2 HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR D.REHLING,P.STENMARK REVDAT 4 31-JAN-24 7B63 1 REMARK REVDAT 3 21-JUL-21 7B63 1 JRNL REVDAT 2 07-APR-21 7B63 1 JRNL REVDAT 1 24-MAR-21 7B63 0 JRNL AUTH D.REHLING,S.M.ZHANG,A.S.JEMTH,T.KOOLMEISTER,A.THROUP, JRNL AUTH 2 O.WALLNER,E.SCALETTI,T.MORIYAMA,R.NISHII,J.DAVIES, JRNL AUTH 3 M.DESROSES,S.G.RUDD,M.SCOBIE,E.HOMAN,U.W.BERGLUND,J.J.YANG, JRNL AUTH 4 T.HELLEDAY,P.STENMARK JRNL TITL CRYSTAL STRUCTURES OF NUDT15 VARIANTS ENABLED BY A POTENT JRNL TITL 2 INHIBITOR REVEAL THE STRUCTURAL BASIS FOR THIOPURINE JRNL TITL 3 SENSITIVITY. JRNL REF J.BIOL.CHEM. V. 296 00568 2021 JRNL REFN ESSN 1083-351X JRNL PMID 33753169 JRNL DOI 10.1016/J.JBC.2021.100568 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0258 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 60.24 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 45895 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.167 REMARK 3 FREE R VALUE : 0.196 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.892 REMARK 3 FREE R VALUE TEST SET COUNT : 2245 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.64 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3227 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.82 REMARK 3 BIN R VALUE (WORKING SET) : 0.2630 REMARK 3 BIN FREE R VALUE SET COUNT : 162 REMARK 3 BIN FREE R VALUE : 0.2590 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2512 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 65 REMARK 3 SOLVENT ATOMS : 348 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.51 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.50600 REMARK 3 B22 (A**2) : 0.83200 REMARK 3 B33 (A**2) : 0.63300 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.26600 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.082 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.083 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.058 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.688 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.971 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.962 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2667 ; 0.014 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 2354 ; 0.001 ; 0.018 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3633 ; 1.827 ; 1.662 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5485 ; 1.455 ; 1.592 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 312 ; 7.474 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 142 ;32.511 ;23.239 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 427 ;12.711 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;16.833 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 297 ; 0.091 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2990 ; 0.012 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 568 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 445 ; 0.211 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 27 ; 0.183 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1242 ; 0.173 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 255 ; 0.184 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1251 ; 2.240 ; 2.260 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1250 ; 2.239 ; 2.259 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1562 ; 3.220 ; 3.389 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1563 ; 3.219 ; 3.390 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1416 ; 3.310 ; 2.673 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1417 ; 3.309 ; 2.673 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2071 ; 5.145 ; 3.831 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2072 ; 5.143 ; 3.832 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK BULK SOLVENT REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THEIR REMARK 3 RIDING POSITIONS REMARK 4 REMARK 4 7B63 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-DEC-20. REMARK 100 THE DEPOSITION ID IS D_1292112720. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-FEB-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MAX IV REMARK 200 BEAMLINE : BIOMAX REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91840 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45919 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 60.240 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.63 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5LPG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.57 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS PH 8.0, 0.2 M SODIUM REMARK 280 ACETATE, 38% PEG 4000, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 22.82050 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMER REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMER REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3340 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14150 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -26.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 THR A 2 REMARK 465 ALA A 3 REMARK 465 SER A 4 REMARK 465 ALA A 5 REMARK 465 GLN A 6 REMARK 465 PRO A 7 REMARK 465 ARG A 8 REMARK 465 MET B 1 REMARK 465 THR B 2 REMARK 465 ALA B 3 REMARK 465 SER B 4 REMARK 465 ALA B 5 REMARK 465 GLN B 6 REMARK 465 PRO B 7 REMARK 465 ARG B 8 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 329 O HOH A 335 1.83 REMARK 500 O HOH A 335 O HOH A 364 2.07 REMARK 500 O HOH B 399 O HOH B 431 2.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER B 37 -153.77 -82.07 REMARK 500 PRO B 130 151.47 -45.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY A 36 SER A 37 -147.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 202 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 63 OE1 REMARK 620 2 GLU A 67 OE2 87.9 REMARK 620 3 HOH A 438 O 163.6 87.1 REMARK 620 4 HOH A 444 O 85.3 101.1 80.4 REMARK 620 5 HOH A 456 O 111.0 83.1 83.9 163.4 REMARK 620 N 1 2 3 4 DBREF 7B63 A 1 164 UNP Q9NV35 NUD15_HUMAN 1 164 DBREF 7B63 B 1 164 UNP Q9NV35 NUD15_HUMAN 1 164 SEQRES 1 A 164 MET THR ALA SER ALA GLN PRO ARG GLY ARG ARG PRO GLY SEQRES 2 A 164 VAL GLY VAL GLY VAL VAL VAL THR SER CYS LYS HIS PRO SEQRES 3 A 164 ARG CYS VAL LEU LEU GLY LYS ARG LYS GLY SER VAL GLY SEQRES 4 A 164 ALA GLY SER PHE GLN LEU PRO GLY GLY HIS LEU GLU PHE SEQRES 5 A 164 GLY GLU THR TRP GLU GLU CYS ALA GLN ARG GLU THR TRP SEQRES 6 A 164 GLU GLU ALA ALA LEU HIS LEU LYS ASN VAL HIS PHE ALA SEQRES 7 A 164 SER VAL VAL ASN SER PHE ILE GLU LYS GLU ASN TYR HIS SEQRES 8 A 164 TYR VAL THR ILE LEU MET LYS GLY GLU VAL ASP VAL THR SEQRES 9 A 164 HIS ASP SER GLU PRO LYS ASN VAL GLU PRO GLU LYS ASN SEQRES 10 A 164 GLU SER TRP GLU TRP VAL PRO TRP GLU GLU LEU PRO PRO SEQRES 11 A 164 LEU ASP GLN LEU PHE TRP GLY LEU ARG CYS LEU LYS GLU SEQRES 12 A 164 GLN GLY TYR ASP PRO PHE LYS GLU ASP LEU ASN HIS LEU SEQRES 13 A 164 VAL GLY TYR LYS GLY ASN HIS LEU SEQRES 1 B 164 MET THR ALA SER ALA GLN PRO ARG GLY ARG ARG PRO GLY SEQRES 2 B 164 VAL GLY VAL GLY VAL VAL VAL THR SER CYS LYS HIS PRO SEQRES 3 B 164 ARG CYS VAL LEU LEU GLY LYS ARG LYS GLY SER VAL GLY SEQRES 4 B 164 ALA GLY SER PHE GLN LEU PRO GLY GLY HIS LEU GLU PHE SEQRES 5 B 164 GLY GLU THR TRP GLU GLU CYS ALA GLN ARG GLU THR TRP SEQRES 6 B 164 GLU GLU ALA ALA LEU HIS LEU LYS ASN VAL HIS PHE ALA SEQRES 7 B 164 SER VAL VAL ASN SER PHE ILE GLU LYS GLU ASN TYR HIS SEQRES 8 B 164 TYR VAL THR ILE LEU MET LYS GLY GLU VAL ASP VAL THR SEQRES 9 B 164 HIS ASP SER GLU PRO LYS ASN VAL GLU PRO GLU LYS ASN SEQRES 10 B 164 GLU SER TRP GLU TRP VAL PRO TRP GLU GLU LEU PRO PRO SEQRES 11 B 164 LEU ASP GLN LEU PHE TRP GLY LEU ARG CYS LEU LYS GLU SEQRES 12 B 164 GLN GLY TYR ASP PRO PHE LYS GLU ASP LEU ASN HIS LEU SEQRES 13 B 164 VAL GLY TYR LYS GLY ASN HIS LEU HET SYW A 201 32 HET MG A 202 1 HET SYW B 201 32 HETNAM SYW (R)-6-((2-METHYL-4-(1-METHYL-1H-INDOLE-5-CARBONYL) HETNAM 2 SYW PIPERAZIN-1-YL)SULFONYL)BENZO[D]OXAZOL-2(3H)-ONE HETNAM MG MAGNESIUM ION HETSYN SYW 6-[(2~{R})-2-METHYL-4-(1-METHYLINDOL-5-YL)CARBONYL- HETSYN 2 SYW PIPERAZIN-1-YL]SULFONYL-3~{H}-1,3-BENZOXAZOL-2-ONE; HETSYN 3 SYW TH7755 FORMUL 3 SYW 2(C22 H22 N4 O5 S) FORMUL 4 MG MG 2+ FORMUL 6 HOH *348(H2 O) HELIX 1 AA1 THR A 55 ALA A 69 1 15 HELIX 2 AA2 GLU A 86 ASN A 89 5 4 HELIX 3 AA3 GLU A 126 LEU A 128 5 3 HELIX 4 AA4 PRO A 130 LEU A 134 5 5 HELIX 5 AA5 PHE A 135 GLN A 144 1 10 HELIX 6 AA6 LEU A 153 VAL A 157 5 5 HELIX 7 AA7 THR B 55 ALA B 69 1 15 HELIX 8 AA8 GLU B 86 ASN B 89 5 4 HELIX 9 AA9 GLU B 126 LEU B 128 5 3 HELIX 10 AB1 PRO B 130 LEU B 134 5 5 HELIX 11 AB2 PHE B 135 GLN B 144 1 10 HELIX 12 AB3 LEU B 153 VAL B 157 5 5 SHEET 1 AA1 4 GLY A 47 HIS A 49 0 SHEET 2 AA1 4 GLY A 13 THR A 21 -1 N VAL A 16 O GLY A 48 SHEET 3 AA1 4 TYR A 90 VAL A 101 1 O ILE A 95 N GLY A 17 SHEET 4 AA1 4 LEU A 72 ILE A 85 -1 N SER A 79 O LEU A 96 SHEET 1 AA2 3 PHE A 43 GLN A 44 0 SHEET 2 AA2 3 CYS A 28 ARG A 34 -1 N GLY A 32 O GLN A 44 SHEET 3 AA2 3 ASN A 117 PRO A 124 -1 O GLU A 118 N LYS A 33 SHEET 1 AA3 4 GLY B 47 HIS B 49 0 SHEET 2 AA3 4 GLY B 13 THR B 21 -1 N VAL B 16 O GLY B 48 SHEET 3 AA3 4 TYR B 90 VAL B 101 1 O ILE B 95 N GLY B 15 SHEET 4 AA3 4 LEU B 72 ILE B 85 -1 N SER B 83 O TYR B 92 SHEET 1 AA4 3 PHE B 43 GLN B 44 0 SHEET 2 AA4 3 CYS B 28 ARG B 34 -1 N GLY B 32 O GLN B 44 SHEET 3 AA4 3 ASN B 117 PRO B 124 -1 O GLU B 118 N LYS B 33 LINK OE1 GLU A 63 MG MG A 202 1555 1555 2.23 LINK OE2 GLU A 67 MG MG A 202 1555 1555 2.34 LINK MG MG A 202 O HOH A 438 1555 1555 2.20 LINK MG MG A 202 O HOH A 444 1555 1555 2.13 LINK MG MG A 202 O HOH A 456 1555 1555 2.78 CRYST1 63.602 45.641 67.023 90.00 116.00 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015723 0.000000 0.007668 0.00000 SCALE2 0.000000 0.021910 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016600 0.00000